IFNG and B-cell chronic lymphocytic leukemia: This report describes a previously unreported approach for treating U-CLL by using measurements of NK cell function and its subsets, IFN-g and IL-10 levels, absolute monocyte count, flow cytometry, FISH analysis, and molecular pathology while tailoring the dose and frequency of IL-2 and targeted therapy in response to the immune effector cells.